Selected News & Events
Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for Treatment of Duchenne Muscular Dystrophy
Stealth Biotherapeutics Announces Data from ReCLAIM-2 Phase 2 Trial of Elamipretide in Geographic Atrophy
Stealth BioTherapeutics Announces New SBT-272 Data and Trial Initiation
Stealth BioTherapeutics Receives Orphan Drug Designation from FDA for Elamipretide for the Treatment of Friedreich’s Ataxia
Events Calendar
No events listed at this time.
@StealthBT on Twitter
Twitter feed is not available at the moment.
Contact Us
Stealth BioTherapeutics
275 Grove Street, Suite 3-107
Newton, MA 02466
(617) 600-6888
info@stealthbt.com